September 18, 2019
In the last year, a study presented at IDWeek 2018 and subsequently published in Clinical Infectious Diseases describing gender disparities in academic advancement within the field of infectious diseases joined a growing body of literature demonstrating an achievement gap between male and female faculty in academic medicine.
Read More
Advocacy efforts promoting the importance of vaccines have never been more important, and our voices make a difference.
Read More
In this feature, a panel of IDSA members identifies and critiques important new studies in the current literature that have a significant impact on the practice of infectious diseases medicine.
Serious Bacterial Infections in Neonates: Is a Single Fever Enough? and Short-Course Primaquine Non-Inferior to Standard Treatment for P. vivax Malaria
Read More
The Society for Healthcare Epidemiology of America is offering an online training course for students, trainees, physicians and other healthcare professionals in infectious diseases to build their understanding of healthcare epidemiology, infection control and antimicrobial stewardship.
Read More
The Human Vaccines Project and Michelson Medical Research Foundation are accepting applications now through Oct. 31 for 2020 Michelson Prizes supporting innovative immunology research.
Read More
IDSA, HIVMA and PIDS have created a 2020 presidential election Toolkit for Action to help members make the most of opportunities during the campaign season to highlight infectious diseases and HIV funding and policies as national priorities.
Read More
Please join us at IDWeek 2019 for the annual Ryan White Medical Providers Coalition luncheon from 12 p.m. to 1:30 p.m. on Thursday, Oct 3.
Read More
In a policy paper published online in Clinical Infectious Diseases, HIVMA, IDSA and the American Academy of HIV Medicine have called for the adoption of strategies as part of existing hospital antibiotic stewardship programs to ensure oversight of antiretroviral treatments for patients with HIV.
Read More
Responding to safety concerns that stemmed from an advertising campaign seeking lawsuit plaintiffs among people reporting serious side effects related to taking Truvada, the chairs of the HIV Medicine Association and the American Academy of HIV Medicine wrote this POZ opinion piece, encouraging people living with HIV to discuss their treatment options with their providers, and reinforcing the United States Preventive Services Task Force Grade A recommendation for Truvada for PrEP.
Read More
The U.S. Food and Drug Administration’s approval of pretomanid, a new tuberculosis treatment that is part of a three-drug regimen effective against extensively drug-resistant disease, represented a significant stride against the world’s leading infectious disease killer.
Read More
Contingencies Magazine spoke with IDSA Senior Vice President, Public Policy and Government Relations Amanda Jezek on drug resistant pathogens and antibiotics and the race against the clock to develop treatment options.
Read More
Here’s a glance at the latest discussions happening on MyIDSA, IDSA’s members-only online community (login required).
Read More